About Essen BioScience
Essen BioScience is a company based in Ann Arbor (United States) founded in 1999 was acquired by Sartorius in March 2017. Essen BioScience operates in a competitive market with competitors including Olympus, Park Systems, Phase Focus, Tomocube and FEI Company, among others.
- Headquarter Ann Arbor, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website essenbioscience.com
- Social LinkedIn X Facebook
- Acquired by Sartorius (Mar 2017)
Funding Insights of Essen BioScience
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Essen BioScience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2014 | – | Series A | – | SFW Capital Partners | – |
2 investors in total: 2 institutional.
Investors in Essen BioScience
Essen BioScience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Sartorius and SFW Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
SFW Capital Partners is focused on private equity investments in industrial and life sciences technology sectors. | 2007 | sfwcap.com | Rye, United States | |
Laboratory and biopharmaceutical equipment is developed for production processes. | 1870 | sartorius.com | Gottingen, Germany |
Investor details for Essen BioScience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Essen BioScience
3 dated milestones of Essen BioScience across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Essen BioScience is founded.
- Funding First funding round.
- Exit Acquired by Sartorius.
Competitors of Essen BioScience
Essen BioScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Olympus, Park Systems, Phase Focus, Tomocube and FEI Company, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| olympus-global.com | 1919 | Tokyo, Japan | – | 35,933 | Manufacturer of imaging and surgical products | |
| parksystems.com | 1997 | Suwon-si, South Korea | – | – | Scanning probe microscopes are manufactured for nanoimaging applications. | |
| phasefocus.com | 2006 | Sheffield, United Kingdom | $12.08M | 10 | Provider of virtual lens that generates High definition images without high-quality lenses | |
| tomocube.com | 2015 | Daejeon, South Korea | $2M | – | Holographic microtomography is utilized for live cell imaging in microscopy. | |
| fei.com | 1971 | Hillsboro, United States | $300,000 | 378 | TEM and SEM microscopy solutions for nanoscale imaging are manufactured. | |
| molecularvista.com | 2011 | San Jose, United States | $660,000 | 11 | Manufacturer of photo-induced force microscopic (PiFM) systems | |
| m2lasers.com | 2006 | Glasgow, United Kingdom | $30.74M | 112 | Light-sheet microscopy systems are developed for biosciences verticals. | |
| viventis-microscopy.com | 2017 | Lausanne, Switzerland | – | – | Developer of light sheet microscopes for live imaging | |
| crestoptics.com | 2010 | Rome, Italy | – | – | Microscopy devices for diagnostic applications are manufactured in Italy. | |
| wooptix.com | 2016 | Madrid, Spain | $24.92M | – | Application that allows 3D capture using single standard camera |
Detailed competitors of Essen BioScience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Essen BioScience
The website of Essen BioScience (essenbioscience.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 4.8% vs previous month
Websites whose visitors overlap most with Essen BioScience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| aragenbio.com | 100% | 3.3K | #5,456,832 | View details | |
bioprodmag.com | bioprodmag.com | 100% | – | – | – |
| jmbioscience.com | 100% | – | – | View details | |
| biosci-intl.com | 100% | – | #2,111,411 | View details | |
| sourcebioscience.com | 100% | 10.5K | #1,618,265 | View details |
Latest news on Essen Bioscience
Complete news archive for Essen BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Essen BioScience
10 companies that operate in the same segment as Essen BioScience (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Essen BioScience
Essen BioScience was founded in 1999 and raised its 1st funding round 15 years after it was founded.
Essen BioScience is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Essen BioScience was founded in 1999 in Ann Arbor, United States. Operations focus on the development, manufacturing, and marketing of cell-based in-vitro assays and instrumentation within the biotechnology sector. Key products include FLIPR for optical screening of G-protein coupled receptors and IonWorks for high-throughput electrophysiology in ion channel drug discovery. The IncuCyte system supports real-time live-cell imaging and data analysis inside incubators.
Essen BioScience's top competitors include Olympus, Park Systems and Tomocube.
Essen BioScience has 2 investors. Key investors include Sartorius, and SFW Capital Partners.
Yes. Essen BioScience was acquired by Sartorius in March 2017.